- Home
- FRHC vs TECH Comparison
FRHC vs TECH Comparison
Compare FRHC & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FRHC | TECH |
|---|---|---|
| Founded | N/A | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3B | 11.2B |
| IPO Year | 1996 | 1995 |
Fundamental Metrics
Financial Performance| Metric | FRHC | TECH |
|---|---|---|
| Price | $169.78 | $72.32 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $71.82 |
| AVG Volume (30 Days) | 84.2K | ★ 3.2M |
| Earning Date | 06-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.62% |
| EPS Growth | ★ 79.29 | N/A |
| EPS | 0.52 | ★ 0.81 |
| Revenue | ★ $2,191,291,000.00 | $1,219,635,000.00 |
| Revenue This Year | N/A | $2.49 |
| Revenue Next Year | N/A | $6.40 |
| P/E Ratio | $314.79 | ★ $89.23 |
| Revenue Growth | ★ 6.86 | 5.23 |
| 52 Week Low | $107.98 | $43.20 |
| 52 Week High | $181.27 | $72.62 |
Technical Indicators
Market Signals| Indicator | FRHC | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 65.74 | 67.75 |
| Support Level | $130.97 | $71.89 |
| Resistance Level | $172.24 | N/A |
| Average True Range (ATR) | 6.25 | 0.26 |
| MACD | 1.80 | -0.32 |
| Stochastic Oscillator | 98.15 | 58.22 |
Price Performance
Historical ComparisonAbout FRHC Freedom Holding Corp.
Freedom Holding Corp is a holding company with reportable segments into the following four segments: Brokerage, Banking, Insurance, and Other. The majority of revenue is from the Banking segment. Banking segment consists of the operations of Freedom Bank KZ and Freedom Bank TJ. Geographically, operates in Kazakhstan, Armenia, Cyprus, the USA, and others, with maximum revenue from Kazakhstan.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.